The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
Open accessAbstract
In a large-scale double-blind controlled trial of practolol (200 mg twice daily) in the long-term prophylactic treatment of 3038 patients recovering from acute myocardial infarction treatment was started one to four weeks after the acute attack. The trial was originally planned to include 4000 patients treated for at least a year but had to be terminated prematurely because of the serious oculocutaneous and peritoneal reactions reported elsewhere. Nevertheless, important findings, probably applicable to other beta-adrenoreceptor antagonists, have emerged in relation to mortality and morbidity. (1) The practolol-treated group showed a significant reduction in overall mortality and in sudden deaths; (2) there was a highly significant reduction in "all cardiac events"; (3) the reduction in overall mortality was virtually confined to patients whose original pre-entry infarcts were sited anteriorly; (4) the protective effect of practolol was most evident in those patients with pre-entry anterior infarcts whose blood pressures at entry were below the mean for the trial as a whole; (5) there were highly significant group differences in favour of the drug relating to the incidence of angina pectoris and cardiac arrhythmias, and to the numbers of patients who had to be withdrawn from the trial because of these conditions; (6) significantly more patients were withdrawn from the treatment group because of suspected adverse reactions. It is concluded that practolol used in the long-term treatment of patients who have survived the acute phase of myocardial infarction reduces the death rate when the original infarct is sited anteriorly. It is postulated that the favourable results of the trial were due to beta-adrenoreceptor blockade rather than to some other property specific to practolol itself. Since practolol produces severe side effects in long-term use it is recommended that an alternative beta-adrenoreceptor blocking agent should be used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approaches to Sudden Death from Coronary Heart Disease
LOWN, B., & WOLF, M. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,257
REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION BY TREATMENT WITH ALPRENOLOL
Wilhelmsson, C., Wilhelmsen, L., Vedin, J. A., Tibblin, G., & Werkö, L. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90807-1 · Cited by 459
Adrenergic Effects on Ventricular Vulnerability
HAN, J., DE JALON, P. G., & MOE, G. K. (1964) · Circulation Research · doi:10.1161/01.res.14.6.516 · Cited by 379
SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)
Brown, P., Read, A. E., Baddeley, H., Davies, J. D., & Mcgarry, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90218-9 · Cited by 322
CORONARY PROGNOSTIC INDEX FOR PREDICTING SURVIVAL AFTER RECOVERY FROM ACUTE MYOCARDIAL INFARCTION
NORRIS, R. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90110-8 · Cited by 301
EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION
Snow, P. J. D. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90863-9 · Cited by 247
Ventricular vulnerability during sympathetic stimulation: role of heart rate and blood pressure
Verrier, R. L., Thompson, P. L., & Lown, B. (1974) · Cardiovascular Research · doi:10.1093/cvr/8.5.602 · Cited by 149
REDUCTION OF SUDDEN DEATHS AFTER MYOCARDIAL INFARCTION
Ahlmark, G., Saetre, H., & Korsgren, M. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90299-2 · Cited by 143
ABSENCE OF PROPHYLACTIC EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION
Clausen, J., Felsby, M., Jørgensen, F. S., NIELSEN, B. L., Róin, J., & Strange, B. (1966) · The Lancet · doi:10.1016/s0140-6736(66)90533-2 · Cited by 125
Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs
Khan, M. I., Hamilton, J. T., & Manning, G. W. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90007-0 · Cited by 87
Cited by
The Norwegian Multicenter Study Group (1981) · New England Journal of Medicine · doi:10.1056/nejm198104023041401 · Cited by 1,675
Physiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System
Bleich, H. L., Moore, M. J., & Cryer, P. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008213030806 · Cited by 652
Reminders to Physicians from an Introspective Computer Medical Record: A Two-Year Randomized Trial
McDONALD, C. J., HUI, S. L., SMITH, D. M., TIERNEY, W. M., COHEN, S. J., WEINBERGER, M., & McCABE, G. P. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-130 · Cited by 625
Graboys, T. B., Lown, B., Podrid, P. J., & DeSilva, R. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90307-1 · Cited by 494
Murphy, M. L., Hultgren, H. N., Detre, K., Thomsen, J., Takaro, T., & Study, P. O. T. V. A. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709222971201 · Cited by 473
Kjekshus, J. K. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90888-x · Cited by 357
Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy
Russell, R. O., Moraski, R. E., Kouchoukos, N., Karp, R., Mantle, J. A., Rogers, W. J., Rackley, C. E., Resnekov, L., Falicov, R. E., Al-Sadir, J., et al. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90105-4 · Cited by 334
Secondary prevention after myocardial infarction: A review of long-term trials
May, G. S., Eberlein, K. A., Furberg, C. D., Passamani, E. R., & DeMets, D. L. (1982) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(82)90010-x · Cited by 322
Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
Bangalore, S., Makani, H., Radford, M., Thakur, K., Toklu, B., Katz, S. D., DiNicolantonio, J. J., Devereaux, P. J., Alexander, K. P., Wetterslev, J., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.032 · Cited by 315
Bigger, J. T., Dresdale, R. J., Heissenbuttel, R. H., Weld, F. M., & Wit, A. L. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(77)90005-6 · Cited by 312
Neural and psychologic mechanisms and the problem of sudden cardiac death
Lown, B., Verrier, R. L., & Rabinowitz, S. H. (1977) · The American Journal of Cardiology · doi:10.1016/s0002-9149(77)80044-1 · Cited by 283
Pratt, C. M., Welton, D. E., Squires, W. G., Kirby, T. E., Hartung, G. M., & Miller, R. R. (1981) · Circulation · doi:10.1161/01.cir.64.6.1125 · Cited by 59
Metadata
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1975-09-27
- Volume
- 3
- Issue
- 5986
- Pages
- 735-740
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W4245646533
- Cited by
- 301
- References
- 11
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.